Cargando…

Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease

Diabetic kidney disease (DKD) is one of the most common microvascular complications of diabetes mellitus. However, the pathological mechanisms contributing to DKD are multifactorial and poorly understood. Diabetes is characterized by metabolic disorders that can bring about a series of changes in en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mengdi, Pang, Yanyu, Guo, Yifan, Tian, Lei, Liu, Yufei, Shen, Cun, Liu, Mengchao, Meng, Yuan, Cai, Zhen, Wang, Yuefen, Zhao, Wenjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479190/ https://www.ncbi.nlm.nih.gov/pubmed/36120335 http://dx.doi.org/10.3389/fphar.2022.970601

Ejemplares similares

BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney disease
por: Guo, Yifan, et al.
Publicado: (2023)

Metabolic reprogramming of pulmonary fibrosis
por: Li, Jiaxin, et al.
Publicado: (2022)

The role of metabolic reprogramming in pancreatic cancer chemoresistance
por: Liu, Chang, et al.
Publicado: (2023)

Resveratrol on the Metabolic Reprogramming in Liver: Implications for Advanced Atherosclerosis
por: Ma, Ying, et al.
Publicado: (2021)

Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
por: Xiao, Wenjing, et al.
Publicado: (2021)

Preclinical Absorption, Distribution, Metabolism, and Excretion of Sodium Danshensu, One of the Main Water-Soluble Ingredients in Salvia miltiorrhiza, in Rats
por: Meng, Xiangguo, et al.
Publicado: (2019)

Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis
por: Huang, Chen, et al.
Publicado: (2021)

Propofol inhibits neuroinflammation and metabolic reprogramming in microglia in vitro and in vivo
por: Guan, Shuyuan, et al.
Publicado: (2023)

Uracil restores susceptibility of methicillin-resistant Staphylococcus aureus to aminoglycosides through metabolic reprogramming
por: Fan, Lvyuan, et al.
Publicado: (2023)

Protective effects of mitochondrial fission inhibition on ox-LDL induced VSMC foaming via metabolic reprogramming
por: Fang, Yijin, et al.
Publicado: (2022)

Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
por: Shen, Xuetong, et al.
Publicado: (2023)

Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease
por: Luo, Shilu, et al.
Publicado: (2021)

Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma
por: Qin, Hanjiao, et al.
Publicado: (2023)

Metabolic Reprogramming of Sulfur in Hepatocellular Carcinoma and Sulfane Sulfur-Triggered Anti-Cancer Strategy
por: Zhang, Ximing, et al.
Publicado: (2020)

Krüppel-like factor 15 in liver diseases: Insights into metabolic reprogramming
por: Chen, Hao, et al.
Publicado: (2023)

Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
por: Li, Yin, et al.
Publicado: (2021)

Therapeutic Drug Monitoring and Pharmacogenetic Testing in Northern China
por: Zhang, Chunyan, et al.
Publicado: (2021)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
por: Nong, Shiqi, et al.
Publicado: (2023)

The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease
por: Xia, Ming, et al.
Publicado: (2020)

Exogenous proline enhances susceptibility of NSCLC to cisplatin via metabolic reprogramming and PLK1-mediated cell cycle arrest
por: Han, Bingjie, et al.
Publicado: (2022)

Therapeutic potential of artemisinin and its derivatives in managing kidney diseases
por: Jin, Qi, et al.
Publicado: (2023)

Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials
por: Feng, Qi, et al.
Publicado: (2022)

Therapeutics of Charcot neuroarthropathy and pharmacological mechanisms: A bone metabolism perspective
por: Liu, Liang, et al.
Publicado: (2023)

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
por: Pang, Yuyang, et al.
Publicado: (2023)

Therapeutic effect of fenofibrate for non-alcoholic steatohepatitis in mouse models is dependent on regime design
por: Wang, Xinxue, et al.
Publicado: (2023)

Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
por: Xu, Jie, et al.
Publicado: (2020)

AMPK Activator O304 Protects Against Kidney Aging Through Promoting Energy Metabolism and Autophagy
por: Zhu, Mingsheng, et al.
Publicado: (2022)

Physcion Protects Against Ethanol-Induced Liver Injury by Reprogramming of Circadian Clock
por: Yao, Youli, et al.
Publicado: (2020)

Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism
por: Liu, Ya-Fei, et al.
Publicado: (2023)

Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora
por: Liu, Xianzhi, et al.
Publicado: (2022)

Discovery of Small Molecule NSC290956 as a Therapeutic Agent for KRas Mutant Non-Small-Cell Lung Cancer
por: Zhang, Jiaxin, et al.
Publicado: (2022)

Histone Methyltransferases as Therapeutic Targets for Kidney Diseases
por: Yu, Chao, et al.
Publicado: (2019)

Selecting the right therapeutic target for kidney disease
por: Buvall, Lisa, et al.
Publicado: (2022)

Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
por: Gu, Yue-Yu, et al.
Publicado: (2021)

Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice
por: Pi, Aiwen, et al.
Publicado: (2021)

The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity
por: Zhao, Jing-Li, et al.
Publicado: (2022)

A nano-preparation approach to enable the delivery of daphnoretin to potentiate the therapeutical efficacy in hepatocellular cancer
por: Zhu, Guanglin, et al.
Publicado: (2022)

Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools
por: Knoppert, Sebastian N., et al.
Publicado: (2019)

A Metabolic Profiling Study of Realgar-Induced Acute Kidney Injury in Mice
por: Zhang, Sheng, et al.
Publicado: (2021)

Exploring the Critical Components and Therapeutic Mechanisms of Perilla frutescens L. in the Treatment of Chronic Kidney Disease via Network Pharmacology
por: Yong, Chen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1s1hkumd3egkh5m5pmhll80paf